IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 217 filers reported holding IMMUNOMEDICS INC in Q1 2019. The put-call ratio across all filers is 0.28 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $21,115,000 | +154.8% | 248,322 | +6.2% | 0.02% | +150.0% |
Q2 2020 | $8,286,000 | +232.0% | 233,811 | +26.3% | 0.01% | +200.0% |
Q1 2020 | $2,496,000 | -50.8% | 185,134 | -22.8% | 0.00% | -50.0% |
Q4 2019 | $5,076,000 | +61.5% | 239,898 | +1.2% | 0.00% | +33.3% |
Q3 2019 | $3,144,000 | +29.3% | 237,078 | +35.3% | 0.00% | +50.0% |
Q2 2019 | $2,431,000 | +26.2% | 175,268 | +74.7% | 0.00% | 0.0% |
Q1 2019 | $1,927,000 | +71.7% | 100,301 | +27.6% | 0.00% | +100.0% |
Q4 2018 | $1,122,000 | -63.7% | 78,631 | -47.0% | 0.00% | -66.7% |
Q3 2018 | $3,092,000 | -30.1% | 148,425 | -20.6% | 0.00% | -25.0% |
Q2 2018 | $4,425,000 | +155.6% | 186,928 | +57.8% | 0.00% | +100.0% |
Q1 2018 | $1,731,000 | -17.4% | 118,462 | -8.6% | 0.00% | 0.0% |
Q4 2017 | $2,095,000 | -41.3% | 129,626 | -49.2% | 0.00% | -50.0% |
Q3 2017 | $3,571,000 | +44.8% | 255,417 | -8.6% | 0.00% | +33.3% |
Q2 2017 | $2,467,000 | +128.2% | 279,405 | +67.2% | 0.00% | +50.0% |
Q1 2017 | $1,081,000 | +163.7% | 167,077 | +49.6% | 0.00% | +100.0% |
Q4 2016 | $410,000 | +382.4% | 111,685 | +328.7% | 0.00% | – |
Q3 2016 | $85,000 | +41.7% | 26,049 | +0.8% | 0.00% | – |
Q2 2016 | $60,000 | -7.7% | 25,855 | -0.1% | 0.00% | – |
Q1 2016 | $65,000 | +14.0% | 25,872 | +38.6% | 0.00% | – |
Q4 2015 | $57,000 | +185.0% | 18,672 | +59.1% | 0.00% | – |
Q3 2015 | $20,000 | -87.0% | 11,735 | -70.9% | 0.00% | – |
Q1 2015 | $154,000 | -20.6% | 40,319 | 0.0% | 0.00% | – |
Q4 2014 | $194,000 | +29.3% | 40,319 | 0.0% | 0.00% | – |
Q3 2014 | $150,000 | – | 40,319 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|